AdvisorShares Pure US Cannabis ETF

MSOS

Market cap $843M

NewLake Capital Partners, Inc. (NLCP) offers defensiveness and a 12% dividend yield, outperforming MSOS over the past three years. MSOS, an ETF heavily concentrated in top cannabis stocks, remains exposed to industry-wide oversupply, margin pressure, and bankruptcy risk. NLCP's low debt, resilient rent collections, and ability to replace tenants provide downside protection absent in MSOS.

I reiterate a Buy rating on AdvisorShares Pure US Cannabis ETF, emphasizing its compelling risk-return profile despite recent volatility. MSOS trades at 1.7x sales, below its historical average of 2x, offering a 17.6% upside to a $4.45 target if multiples revert. Regulatory progress is slow but ongoing; reclassification appears a matter of 'when,' not 'if,' with catalysts tied to legislative and credit access developments.

Retail investors in r/options are making an unusual bet on AdvisorShares Pure US Cannabis ETF ( NYSEARCA:MSOS ), and the activity is hard to ignore.

The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago.

President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure US Cannabis ETF, joins Asking for a Trend to explain where the cannabis industry stands right now.

The AdvisorShares Pure US Cannabis ETF has spent the last month on a rollercoaster.

Santa Rally fizzled as markets stumbled, but ETFs tied to cannabis (MSOS, WEED), metals (SLV, PPLT) and space (UFO) surged.

Silver, gold & platinum ETFs (SLVP, SILJ, GOEX) crushed it in 2025, while MSOS, MEME & VIXY lagged amid policy, hype & calm markets.

Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.

The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-term opportunities for marijuana stock investors and those looking to get invested in the industry. Cannabis stocks benefit from increasing consumer demand and acceptance. Medical cannabis adoption supports consistent revenue and defensive market positioning.